SCHEMBL19475309

SCHEMBL19475309

Nc1ccc(-c2cc(C(=O)N3CCOCC3)c3cc(Cl)ccc3n2)nc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MOK Q9UQ07 4/20 0.72
LMNA P02545 2/20 0.57
ALDH1A1 P00352 8/20 0.54
HPGD P15428 5/20 0.54
HSD17B10 Q99714 4/20 0.54
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
POLB P06746 3/20 0.54
MAPT P10636 2/20 0.54
USP2 O75604 2/20 0.54
PKM P14618 1/20 0.54
ALOX15 P16050 1/20 0.54
KDM4E B2RXH2 5/20 0.51
GAA P10253 3/20 0.51
TSHR P16473 2/20 0.51
CASP1 P29466 1/20 0.51
CASP7 P55210 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
SMN1; SMN2 Q16637 2/20 0.49
RXFP1 Q9HBX9 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19475308 0.87 ALDH1A1 (0.69) MOKLMNAALDH1A1HPGDHSD17B10
SCHEMBL19475458 0.84 MOK (0.72) MOKLMNAALDH1A1HPGDHSD17B10
SCHEMBL19475352 0.84 MOK (1.00) MOKLMNAALDH1A1HPGDHSD17B10
SCHEMBL19475342 0.81 PTGES (0.61) MOKALDH1A1HPGDHSD17B10MEN1
SCHEMBL19475304 0.81 MOK (0.73) MOKLMNAALDH1A1HPGDHSD17B10
SCHEMBL30834299 0.80 MOK (0.61) MOKLMNAALDH1A1HPGDHSD17B10
SCHEMBL19508994 0.78 MOK (0.84) MOKLMNAALDH1A1HPGDHSD17B10
SCHEMBL19475514 0.76 MOK (1.00) MOKLMNAALDH1A1HPGDHSD17B10
SCHEMBL19475475 0.74 MOK (1.00) MOKLMNAALDH1A1HPGDHSD17B10
SCHEMBL25228586 0.74 LMNA (0.98) MOKLMNAALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192859-B2 Quinoline compounds as modulators of RAGE activity and uses thereof UNIV NEW YORK (US) 2021-12-07 US disclosed
US-11192859-B2 Quinoline compounds as modulators of RAGE activity and uses thereof UNIV NEW YORK (US) 2021-12-07 US disclosed
US-20190194136-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF UNIV NEW YORK (US) 2019-06-27 US disclosed
US-20190194136-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF UNIV NEW YORK (US) 2019-06-27 US disclosed
WO-2017184547-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF NEW YORK UNIVERSITY (US) 2017-10-26 WO disclosed
WO-2017184547-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF NEW YORK UNIVERSITY (US) 2017-10-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190194136-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF AGER, HMGB1, GPR119 MOK 4420/4885LMNA 793/4885ALDH1A1 1885/4885
US-11192859-B2 Quinoline compounds as modulators of RAGE activity and uses thereof AGER, HMGB1, GPR119 MOK 4420/4885LMNA 793/4885ALDH1A1 1885/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.